Inactive Instrument

Highlights Zogenix, Inc. Nasdaq

Equities

US98978L1052

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

U.S. FDA approves UCB's drug for rare childhood epilepsy	22-03-28	RE
Zogenix Completes $1.9 Billion Buyout by UCB; Shares Delisted From Nasdaq	22-03-07	MT
UCB Closes Zogenix Acquisition for Nearly $1.9 Billion	22-03-07	MT
UCB BioSciences, Inc. completed the acquisition of Zogenix, Inc..	22-03-03	CI
Zogenix Q4 Loss Narrows, Revenue Increases	22-02-28	MT
Zogenix, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	22-02-28	CI
Zogenix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-28	CI
Earnings Flash (ZGNX) ZOGENIX Posts Q4 Revenue $26.6M	22-02-28	MT
Zogenix Agrees to $1.9 Billion Takeover by UCB; Shares Surge	22-01-19	MT
Zogenix Shares Leap More Than 60% Premarket on UCB Deal	22-01-19	DJ
Zogenix Agrees to $1.9 Billion Takeover by UCB	22-01-19	MT
Belgium's UCB To Buy US Biopharmaceutical Group Zogenix For Up To $2 Billion	22-01-19	MT
UCB to Acquire Zogenix in Deal Valued at Up to $1.9 Billion	22-01-19	DJ
UCB BioSciences, Inc. submitted a written non-binding offer to acquire Zogenix, Inc. for approximately $1.5 billion.	22-01-18	CI
Zogenix Submits New Drug Application for FINTEPLA® (Fenfluramine) in Japan for the Treatment of Epileptic Seizures Associated with Dravet Syndrome	21-12-21	CI
Zogenix Seeks European Approval for Expanded Use of Fintepla	21-12-20	MT
Zogenix Submits Type II Variation Application to the European Medicines Agency to Expand the Use of FINTEPLA® (Fenfluramine) for the Treatment of Seizures Associated with Lennox-Gastaut Syndrome	21-12-20	CI
Zogenix To Present New FINTEPLA? (fenfluramine) Data at AES 2021	21-12-02	CI
Zogenix Announces U.S. FDA Acceptance for Priority Review of Supplemental New Drug Application for FINTEPLA? (Fenfluramine) for the Treatment of Seizures Associated with Lennox-Gastaut Syndrome	21-12-01	CI
Earnings Flash (ZGNX) ZOGENIX Reports Q3 Revenue $22.6M, vs. Street Est of $22.7M	21-11-04	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Zogenix, Inc. Nasdaq

Equities

US98978L1052

Highlights

Filters